Track Thermo Fisher Scientific Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Thermo Fisher Scientific Inc. TMO · Stock Open Thermo Fisher Scientific Inc. in new tab

523.44 USD
P/E
28.17
EPS
18.21
Yield
0.35%
Safety Score
91
P/B
3.67
ROE
13.52
Beta
0.87
Target Price
596.26 USD
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

🧾 Earnings Recap – Q1 2026

Thermo Fisher delivered a robust Q1 with 6% revenue growth to $11.01 billion, driven by strength in biotech and pharma markets, while maintaining disciplined margins and expanding innovative offerings.

  • Revenue increased 6% to $11.01 billion; adjusted EPS up 6% to $5.44, supported by a 21.8% operating margin.
  • Pharma and biotech markets grew mid-single-digit, led by bioproduction, clinical research, and safety channels.
  • Launches included advanced cryo-EM and mass spectrometry solutions, reinforcing industry leadership and customer value.
  • Strategic collaborations with NVIDIA and SHL Medical enhance AI-driven workflows and manufacturing capabilities.
  • End markets are expected to remain resilient amid macroeconomic uncertainties and ongoing innovation efforts.
📅
Loading chart...
Key Metrics
Earnings dateJuly 22, 2026
P/E28.17
EPS18.21
Book Value139.75
Price to Book3.67
Debt/Equity82.90
% Insiders0.152%
Growth
Revenue Growth0.06%
Earnings Growth0.11%
Estimates
Forward P/E18.82
Forward EPS27.26
Target Mean Price596.26
Dividend
Dividend Yield0.35%
Annual dividends1.80 USD
Ex-Div. DateJune 15, 2026
Payout9.46%
5y avg Yield0.23%

DCF Valuation

Tweak assumptions to recompute fair value for Thermo Fisher Scientific Inc. (TMO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Thermo Fisher Scientific Inc. Logo Thermo Fisher Scientific Inc. Analysis (TMO)

United States Health Care Official Website Stock

Is Thermo Fisher Scientific Inc. a good investment? Thermo Fisher Scientific Inc. (TMO) is currently trading at 523.44 USD. Market analysts have a consensus price target of 596.26 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 28.17. This valuation is generally in line with the broader market.

Earnings Schedule: Thermo Fisher Scientific Inc. is expected to release its next earnings report on July 22, 2026. The market consensus estimate for Forward EPS is 27.26.

For income investors, Thermo Fisher Scientific Inc. pays a dividend yield of 0.35%. With a payout ratio of 9%, the dividend appears sustainable.

Investor FAQ

Does Thermo Fisher Scientific Inc. pay a dividend?

Yes, it pays an annual dividend of 1.80 USD (0.35% yield).

What asset class is Thermo Fisher Scientific Inc.?

Thermo Fisher Scientific Inc. is classified as a Stock. You can compare it against 8 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 22, 2026. The company currently has a trailing EPS of 18.21.

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
MEX (Mexico) TMO.MX
SAO (Brazil) TMOS34.SA
NYQ (United States) TMO
BUE (Argentina) TMO.BA
FRA (Germany) TN8.F
STU (Germany) TN8.SG
GER (Germany) TN8.DE
VIE (Austria) TMOF.VI
Trades
Dividend Yield
0.35%
5y avg 0.23%
Annual Dividends
1.80USD
Next Ex. Div Date
June 15, 2026
Payout Ratio
9.46%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
2027
1.04 USD
April 15, 2027 (estimated) 0.5425
Jan. 15, 2027 (estimated) 0.5010
2026
1.87 USD
Oct. 15, 2026 (estimated) 0.4963
July 15, 2026 0.4700
April 15, 2026 0.4700
Jan. 15, 2026 0.4300
2025
1.68 USD
Oct. 15, 2025 0.4300
July 15, 2025 0.4300
April 15, 2025 0.4300
Jan. 15, 2025 0.3900
2024
1.52 USD
Oct. 15, 2024 0.3900
July 15, 2024 0.3900
April 15, 2024 0.3900
Jan. 16, 2024 0.3500
2023
1.35 USD
Oct. 13, 2023 0.3500
July 14, 2023 0.3500
April 14, 2023 0.3500
Jan. 16, 2023 0.3000
2022
1.16 USD
Oct. 14, 2022 0.3000
July 15, 2022 0.3000
April 14, 2022 0.3000
Jan. 14, 2022 0.2600
2021
1.00 USD
Oct. 15, 2021 0.2600
July 15, 2021 0.2600
April 16, 2021 0.2600
Jan. 15, 2021 0.2200
2020
0.85 USD
Oct. 15, 2020 0.2200
July 15, 2020 0.2200
April 16, 2020 0.2200
Jan. 15, 2020 0.1900
2019
0.74 USD
Oct. 15, 2019 0.1900
July 16, 2019 0.1900
April 16, 2019 0.1900
Jan. 15, 2019 0.1700
2018
0.66 USD
Oct. 15, 2018 0.1700
July 16, 2018 0.1700
April 16, 2018 0.1700
Jan. 15, 2018 0.1500
2017
0.60 USD
Oct. 16, 2017 0.1500
July 17, 2017 0.1500
April 17, 2017 0.1500
Jan. 16, 2017 0.1500
2016
0.60 USD
Oct. 17, 2016 0.1500
July 15, 2016 0.1500
April 15, 2016 0.1500
Jan. 15, 2016 0.1500
2015
0.60 USD
Oct. 15, 2015 0.1500
July 15, 2015 0.1500
April 15, 2015 0.1500
Jan. 15, 2015 0.1500
2014
0.60 USD
Oct. 15, 2014 0.1500
July 15, 2014 0.1500
April 15, 2014 0.1500
Jan. 15, 2014 0.1500
2013
0.60 USD
Oct. 15, 2013 0.1500
July 15, 2013 0.1500
April 15, 2013 0.1500
Jan. 15, 2013 0.1500
2012
0.39 USD
Oct. 15, 2012 0.1300
July 16, 2012 0.1300
April 16, 2012 0.1300
2001
3.34 USD
Nov. 16, 2001 2.5200
Aug. 9, 2001 0.8200
1996
0.00 USD
Feb. 12, 1996 0.0040
1993
0.04 USD
Aug. 6, 1993 0.0430
Upcoming Dividends
Name Payment Date Status Amount
Thermo Fisher Scientific Inc. Jul 15, 2026 Upcoming 0.47 USD
Thermo Fisher Scientific Inc. Apr 15, 2026 0.47 USD
Thermo Fisher Scientific Inc. Jan 15, 2026 0.43 USD
Thermo Fisher Scientific Inc. Oct 15, 2025 0.43 USD
Stock Splits
Split Date Split Ratio to 1
June 6, 1996 1.500000
May 25, 1995 1.500000
Oct. 29, 1993 1.500000
Nov. 3, 1986 1.500000
Sept. 17, 1985 1.500000
Jan. 4, 1984 1.500000
July 10, 1979 1.500000
Nov. 19, 1973 2.000000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion